Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5199065

ISTISOCICLIB
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
CCC(CC)c1cc(N[C@H]2CC[C@H](N)C2)n2nccc2n1

Basic Information

ChEMBL ID CHEMBL5199065
Name ISTISOCICLIB
Phase Phase II
Structure Type MOL
InChI Key VYKCLMALANGCDF-STQMWFEESA-N

Known Names

Istisociclib KB-00130742 Kb-0742 KB-130742 KB0742 UB-18422
24
Targets
34
Activities
1
Assay Types
30
PK Parameters
20
Publications
6
Known Names
1
Indications

Molecular Properties

287.4
MW (Da)
2.92
ALogP
5
HBA
2
HBD
68.2
PSA (Ų)
0.89
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Single Enantiomer
USAN Stem -ciclib
USAN Year 2024

Extended Properties

Molecular Formula C16H25N5
MW 287.41
Aromatic Rings 2
Heavy Atoms 21
NP-Likeness -0.99

Indications

Neoplasms

Activity Summary

IC50 34 meas. best 8.22

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
CDK9/cyclin T1
CHEMBL2111389
IC50 8.22 8.22 6.0 3
Cyclin-dependent kinase 9
CHEMBL3116
IC50 8.22 8.22 6.0 5
Cyclin-dependent kinase 13
CHEMBL1795192
IC50 6.43 6.43 372.0 1
Cyclin-dependent kinase 2
CHEMBL301
IC50 6.4 6.4 396.0 1
CDK2/Cyclin A1
CHEMBL3038470
IC50 6.4 6.4 397.0 1
Cyclin-dependent kinase 12
CHEMBL3559692
IC50 6.23 6.23 588.0 1
Unchecked
CHEMBL612545
IC50 6.22 6.22 600.0 1
MDA-MB-231
CHEMBL400
IC50 6.06 6.06 880.0 1
BT-549
CHEMBL614072
IC50 6.03 6.03 940.0 1
BT-20
CHEMBL613870
IC50 6.01 6.01 970.0 1
Hs-578T
CHEMBL614645
IC50 5.91 5.91 1230.0 1
CDK3/Cyclin E
CHEMBL3038471
IC50 5.85 4.925 1420.0 2
Cyclin-dependent kinase 7/ cyclin H
CHEMBL2111288
IC50 5.82 5.06 1510.0 2
Cyclin-dependent kinase 5/CDK5 activator 1
CHEMBL1907600
IC50 5.74 5.74 1820.0 1
CDK1/Cyclin A
CHEMBL3038467
IC50 5.53 5.53 2980.0 1
Cyclin-dependent kinase 4/cyclin D1
CHEMBL1907601
IC50 5.5 4.75 3130.0 2
CDK6/cyclin D1
CHEMBL2111455
IC50 5.4 4.7 3950.0 2
Cyclin-dependent kinase 13/Cyclin-K
CHEMBL4296067
IC50 5.3 5.3 5000.0 1
Cytochrome P450 1A2
CHEMBL3356
IC50 4.82 4.82 15300.0 1
Cyclin-dependent kinase 14/Cyclin-Y
CHEMBL4296115
IC50 4.82 4.82 15000.0 1
Cyclin-C/Cyclin-dependent kinase 19
CHEMBL3883323
IC50 4.7 4.7 20000.0 1
CDK18/Cyclin Y
CHEMBL4106161
IC50 4.7 4.7 20000.0 1
CDK17/Cyclin-Y
CHEMBL4523637
IC50 4.7 4.7 20000.0 1
CDK12/Cyclin K
CHEMBL4106169
IC50 4.52 4.52 30000.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 1700.0 ng.hr.mL-1 Mus musculus
AUC 3591.0 ng.hr.mL-1 Rattus norvegicus
AUC 4007.0 ng.hr.mL-1 Canis lupus familiaris
CL 7.0 mL.min-1.kg-1 Mus musculus
CL 5.5 mL.min-1.kg-1 Rattus norvegicus
CL 5.5 mL.min-1.kg-1 Canis lupus familiaris
CL 0.93 mL.min-1.kg-1 Homo sapiens
CL 44.0 mL.min-1.kg-1 Mus musculus
CL 62.0 mL.min-1.kg-1 Rattus norvegicus
CL 38.0 mL.min-1.kg-1 Canis lupus familiaris
CL 1.6 mL.min-1.kg-1 Homo sapiens
CL 23.4 mL.min-1.kg-1 Mus musculus
CL 51.7 mL.min-1.kg-1 Rattus norvegicus
CL 13.4 mL.min-1.kg-1 Canis lupus familiaris
Cmax 1743.15 nM Mus musculus
Cmax 1430.01 nM Rattus norvegicus
Cmax 1718.8 nM Canis lupus familiaris
F 33.0 % Mus musculus
F 84.5 % Rattus norvegicus
F 100.0 % Canis lupus familiaris
T1/2 6.0 hr Mus musculus
T1/2 46.72 hr Rattus norvegicus
T1/2 6.0 hr Canis lupus familiaris
T1/2 6.0 hr Homo sapiens
T1/2 12.92 hr Mus musculus
T1/2 8.5 hr Rattus norvegicus
T1/2 4.717 hr Canis lupus familiaris
T1/2 22.35 hr Homo sapiens
T1/2 6.233 hr Mus musculus
T1/2 1.967 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Cyclin-dependent kinase 9 IC50 = 6.0 nM 8.22 Inhibition of CDK9 (unknown origin) by hotspot kinase assay 35235745
CDK9/cyclin T1 IC50 = 6.0 nM 8.22 Inhibition of CDK9/Cyclin T1 (unknown origin) 35485642
Cyclin-dependent kinase 9 IC50 = 6.0 nM 8.22 Inhibition of CDK9 (unknown origin) in presence of ATP 37837671
CDK9/cyclin T1 IC50 = 6.0 nM 8.22 Inhibition of CDK9/Cyclin T (unknown origin) 38852339
Cyclin-dependent kinase 9 IC50 = 6.0 nM 8.22 Inhibition of CDK9 (unknown origin) by ADP-Glo kinase assay 38564299
Cyclin-dependent kinase 9 IC50 = 6.0 nM 8.22 Inhibition of CDK9 (unknown origin) 38564299
CDK9/cyclin T1 IC50 = 6.0 nM 8.22 Inhibition of human CDK9/Cyclin T1 preincubated for 20 mins followed by 32P-ATP ... 37967851
Cyclin-dependent kinase 9 IC50 = 6.0 nM 8.22 Inhibition of CDK9 (unknown origin) incubated for 120 mins in presence of ATP by... 35814933
Cyclin-dependent kinase 13 IC50 = 372.0 nM 6.43 Inhibition of CDK13 (unknown origin) incubated for 120 mins in presence of ATP b... 35814933
Cyclin-dependent kinase 2 IC50 = 396.0 nM 6.4 Inhibition of CDK2 (unknown origin) incubated for 120 mins in presence of ATP by... 35814933
CDK2/Cyclin A1 IC50 = 397.0 nM 6.4 Inhibition of human CDK2/Cyclin A preincubated for 20 mins followed by 32P-ATP a... 37967851
Cyclin-dependent kinase 12 IC50 = 588.0 nM 6.23 Inhibition of CDK12 (unknown origin) incubated for 120 mins in presence of ATP b... 35814933
Unchecked IC50 = 600.0 nM 6.22 Cytotoxicity against human MT-3 cells assessed as cell growth inhibition incubat... 37967851
MDA-MB-231 IC50 = 880.0 nM 6.06 Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition i... 37967851
BT-549 IC50 = 940.0 nM 6.03 Cytotoxicity against human BT-549 cells assessed as cell growth inhibition incub... 37967851
BT-20 IC50 = 970.0 nM 6.01 Cytotoxicity against human BT-20 cells assessed as cell growth inhibition incuba... 37967851
Hs-578T IC50 = 1230.0 nM 5.91 Cytotoxicity against human Hs-578T cells assessed as cell growth inhibition incu... 37967851
CDK3/Cyclin E IC50 = 1420.0 nM 5.85 Inhibition of human CDK3/Cyclin E preincubated for 20 mins followed by 32P-ATP a... 37967851
Cyclin-dependent kinase 7/ cyclin H IC50 = 1510.0 nM 5.82 Inhibition of human CDK7/Cyclin H preincubated for 20 mins followed by 32P-ATP a... 37967851
Cyclin-dependent kinase 5/CDK5 activator 1 IC50 = 1820.0 nM 5.74 Inhibition of human CDK5/P25 preincubated for 20 mins followed by 32P-ATP additi... 37967851

Literature References

PubMed DOI Target Context # Activities
37967851 10.1021/acs.jmedchem.3c01233 ADMET 48
37967851 10.1021/acs.jmedchem.3c01233 Unchecked 16
37967851 10.1021/acs.jmedchem.3c01233 Hs-578T 5
37967851 10.1021/acs.jmedchem.3c01233 BT-549 5
37967851 10.1021/acs.jmedchem.3c01233 BT-20 5
37967851 10.1021/acs.jmedchem.3c01233 MDA-MB-231 5
37967851 10.1021/acs.jmedchem.3c01233 Cyclin-dependent kinase 9 4
37967851 10.1021/acs.jmedchem.3c01233 CDK3/Cyclin E 2
38564299 10.1021/acs.jmedchem.4c00312 Cyclin-dependent kinase 9 2
37967851 10.1021/acs.jmedchem.3c01233 Cyclin-dependent kinase 4/cyclin D1 2
37967851 10.1021/acs.jmedchem.3c01233 CDK6/cyclin D1 2
37967851 10.1021/acs.jmedchem.3c01233 Cyclin-dependent kinase 7/ cyclin H 2
37967851 10.1021/acs.jmedchem.3c01233 No relevant target 2
35814933 10.1039/d2md00040g Cyclin-dependent kinase 12 1
35814933 10.1039/d2md00040g Cyclin-dependent kinase 16 1
35814933 10.1039/d2md00040g Cyclin-dependent kinase 14 1
35814933 10.1039/d2md00040g Cyclin-dependent kinase 13 1
37837671 10.1016/j.ejmech.2023.115858 Cyclin-dependent kinase 9 1
35814933 10.1039/d2md00040g Cyclin-dependent kinase 4 1
35814933 10.1039/d2md00040g Cyclin-dependent kinase 3 1

Data from ChEMBL 36 via Core Engine